Expression Analysis, Inc., the industry’s leading provider of genomic services for clinical trials and research, announced today a family of grants focused on one unifying purpose: To accelerate research into complex diseases and aid researchers in unlocking biological mysteries.
Dedicated to a deeper understanding of human health and disease, the grant will award four deserving researchers access to Expression Analysis’ state-of-the-art services. Four grants will be awarded; two focusing on genome-wide association studies and two on follow-up to GWAS. Included in all four grants is data analysis through digenysis™ a proprietary analysis tool that simultaneously analyzes allelic and copy number variation, accomplishing in days what can typically take months.
“Genomic technologies play a key role in the diagnosis, treatment and management of complex diseases and, to effectively tackle diseases we need to encourage the best and brightest minds to take risks on novel ideas. Our grant initiative is designed to further research in efforts to identify genetic elements important to human health and disease,” stated Steve McPhail, CEO of Expression Analysis.
New research sheds light on how GLP-1 obesity drugs may change food cravings